Skip to main content
Premium Trial:

Request an Annual Quote

Incyte and Gene Logic Dismiss Patent Suit, Gene Logic Granted License

NEW YORK, Jan 11 - Incyte Genomics and Gene Logic have settled a patent infringement lawsuit filed by Incyte against Gene Logic, the companies said Thursday.

The suit, filed in the U. S. District Court for the Northern District of California, alleged infringement of U.S. Patent Numbers 5,716,785, 5,891,636 and 6,023,659.

Under the settlement agreement, the lawsuits will be dismissed and Gene Logic will have a non-exclusive license to practice the technology described in these patents.

Specific settlement and financial terms were not disclosed, in accordance with the terms of the settlement agreement.

U.S. Patents 5,716,785 and 5,891,636, both entitled “Processes for genetic manipulations using promoters,” cover the use of promoters for RNA amplification and other genetic manipulations.

U. S. Patent 6,023,659, “Database system employing protein function hierarchies for viewing biomolecular sequence data,” covers a relational database system that stores biomolecular sequence information so that it may be catalogued and searched according to one or more protein function hierarchies.
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.